ftInvstr
SAKAR · Healthcare ₹1012.0 +0.0% Mkt Cap ₹2213 Cr

SAKAR

Healthcare Drug Manufacturers - Specialty & Generic
₹1012.0
+0.0% today · 30d +9.9%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SAKAR. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹73 Cr
+38.37% YoY
NET PROFIT
₹10 Cr
+120.17% YoY
OPM
30.59%
+5.93pp YoY
EPS
₹4.62
PE 80.44
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-49.0%, h3=-47.1% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SAKAR80.4413.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
72
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation STRETCHED 20
Growth STRONG 83
Profitability HIGH 75
Technicals STRONG 73
Risk LOW 80
Key Stats
TTM PE
80.44
P/B
7.6
52W HIGH
₹1024.0
OFF HIGH
-1.17%
MKT CAP
₹2213 Cr
◉ Active Signals
MACDBullish11.1821
RSI(14)Bullish65.9
Near 52W HighBullish-1.17
Street Consensus
1 analyst
₹1020.0
mean target
Low ₹1020.0Now ₹1012.0High ₹1020.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SAKAR and at what entry.

Sign up freeSign in